Last reviewed · How we verify
NCT05576259
oVRcome - Self Guided Virtual Reality for Social Anxiety Disorder
NA trial testing oVRcome phone app with headset in Social Anxiety in 100 participants. Completed in 1 November 2023.
1 July 2023
Quick facts
| Lead sponsor | University of Otago |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 8 October 2022 |
| Primary completion | 1 July 2023 |
| Estimated completion | 1 November 2023 |
| Sites | 1 location across New Zealand |
Drugs / interventions tested
- oVRcome phone app with headset
Conditions studied
- Social Anxiety — all drugs for Social Anxiety →
Sponsor
University of Otago
Who can join
Adults 18 to 64, any sex, with Social Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Social anxiety is characterised by excessive fear of being negatively judged, embarrassed or humiliated during social interactions and is common with a lifetime prevalence of 12.1%. Cognitive behavioural therapy is the first line of treatment, but people may not seek treatment due to a number of factors including the discomfort experienced in seeking help, inconvenience, and the experience of psychotherapy itself. With Virtual Reality (VR), users can have increased control in how gradually they expose themselves to social situations. In studies of VR in people with specific phobias, 76% of people prefer VR exposure to in vivo exposure. There is emerging evidence for the use of VR in social phobia. oVRcome, is a self-help VRET for social anxiety symptoms and specific phobias, that is delivered through a smartphone application (app) in combination with a low cost headset that holds the smartphone and uses 360º video. This study will evaluate the effectiveness of the oVRcome social anxiety program for social anxiety symptoms. We hypothesize that oVRcome will reduce social anxiety symptom severity over a 6-week treatment period compared to waiting-list control
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A self-guided virtual reality solution for social anxiety: Results from a randomized controlled study.
Lacey C, Frampton C, Beaglehole B. · · 2024 · PMID 39515186 · DOI 10.1016/j.jpsychires.2024.10.032
Verify or expand the search:
- PubMed search for NCT05576259
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Social Anxiety
Currently open trials in the same condition.
- NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
- NCT07259005 — Breathe Hard to Breathe Easy: Online Breathwork-Assisted Therapy for Social Anxiety · NA · recruiting
- NCT06465589 — Variations of Anonymity, Transparency, and Efficacy in Digital Health Applications · NA · active not recruiting
- NCT06409247 — iExposure Intervention for Social Anxiety · NA · active not recruiting
- NCT06564402 — Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety · NA · recruiting
Other University of Otago trials
Trials by the same sponsor.
- NCT05030909 — Feasibility Study of a Group Intervention for Youth Wellbeing · NA · recruiting
- NCT05581797 — Psilocybin-assisted Interpersonal Therapy for Depression · NA · completed
- NCT05090046 — Understanding Neurocognitive Impairment After Trauma Exposure · completed
- NCT05052333 — Examine the Psychosocial Impacts of COVID-19 Pandemic. · completed
- NCT04909177 — oVRcome Self-guided Virtual Reality for Specific Phobias · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05576259 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Otago
- Last refreshed: 9 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05576259.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing